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htcense.Abstract Purpose: To detect the diagnostic accuracy of dynamic contrast enhanced magnetic res-
onance imaging (DCE-MRI) in the assessment of myometrium and cervix inﬁltration and lymph
node (L.N) status in patients with endometrial carcinoma.
Patients and methods: Forty patients with pathologically proven endometrial carcinoma underwent
preoperative MRI assessment in the National Cancer Institute, Cairo University, Egypt over three
years from 2009 to 2012. Every case had one stage for the T2 weighted images (T2 WIs) alone and
another stage for the combined T2 and DCE images according to the revised international federa-
tion of gynecology and obstetrics (FIGO) classiﬁcation. The pathological ﬁndings after surgery
were the reference standard.
Results: The sensitivity, speciﬁcity, positive predictive value (PPV), negative predictive value (NPV)
and diagnostic accuracy of T2 WIs in detection of deep myometrial invasion were 80%, 72%, 70%,
84% and 79%, respectively and 87%, 90%, 85%, 92%and 87%, respectively forDCE-MRI. For cer-
vical inﬁltration, T2WIs showed 78.5%, 88%, 73%, 90.5% and 82.5%, respectively while DCE-MRI
showed 92%, 97%, 92%, 97% and 95%, respectively. T2 WIs and DCE-MRI had 100% sensitivity
and 85% speciﬁcity for the detection of L.N metastasis.
Conclusion: DCE-MRI can accurately detect invasion of the myometrium and cervix in cases of
endometrial carcinoma.
 2013 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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Endometrial carcinoma is the fourth most common cancer in
females and the most common malignancy of the female repro-
ductive tract (1).
Treatment planning of patients with endometrial carcinoma
depends on accurate staging of the disease, nodal status and
the histologic grade (2) as stages higher than the stage I
(who are treated by total hysterectomy and bilateral sal-
pingo-oophorectomy) need additional treatment in the form
of lymph node dissection and adjuvant radiotherapy (3).
Extension of the tumor into the myometrium is probably
the single most important morphologic prognostic factor as
it correlates with tumor grade, tumor extension into the cervix
and the prevalence of lymph node metastases as incidence of
lymph node metastases increases from 3% with stage IB to
46% with stage IC (4).
The presence and depth of cervical inﬁltration also affect
the prognosis and management of endometrial carcinoma (5).
The presence of myometrial invasion greater than 50% or
the presence of a large tumor (>2 cm in diameter or ﬁlling
the endometrial cavity) indicates a high risk of nodal disease,
even in apparent stage I disease; therefore, the presence of
any of these features suggests the beneﬁt from surgical resec-
tion of the lymph nodes (6).
The evaluation of the extent of myometrial invasion by
gross inspection at surgery or at frozen section remains inaccu-
rate in a signiﬁcant proportion of patients (7).
Although MRI is not formally incorporated into the revised
FIGO staging system (Table 1) (8), it is widely used by clini-
cians to assess the stage of the disease in both endometrial
and cervical cancers (9). However, there is no certain technique
in the literature regarding the best MRI protocol in gynecolog-
ical tumors which is considered worldwide accepted (10,11).
The aims of this study were to evaluate the accuracy of
DCE-MRI in the identiﬁcation of myometrial and cervical
stromal invasion and lymph node status in cases of endome-
trial carcinoma.
2. Patients and methods
Forty patients with pathologically proven primary endometrial
carcinoma were included in this study. The age of the patients
ranged from 39 to 78 years (with mean age 59). All patientsTable 1 Revised FIGO staging of endometrial carcinoma.
Stage I Conﬁned to corpu
IA No or less than ha
IB Invasion equal to
Stage II Tumor invades cer
Stage III Local and/or regio
IIIA Invasion of serosa
IIIB Invasion of vagina
IIIC Metastasis to pelvi
IIIC1 Positive pelvic nod
IIIC2 Positive para-aorti
Stage IV Tumor invades bla
IVA Tumor invasion of
IVB Distant metastasesunderwent preoperative assessment with dynamic MRI study
of the pelvis and lower abdomen.
MRI examinations were done with 1.5 Tesla MRI machine
(GE machine, USA) using phased-array pelvic coils in a supine
position with partially full urinary bladder. An antiperistaltic
agent such as buscopan (20 mg butylscopolamine) was admin-
istered intramuscularly before the examination to reduce arti-
facts from the small bowel peristalsis. Each examination
included precontrast, high resolution Fast Recovery Fast Spin
Echo (FRFSE) sequences for better tumor delineation using
T2W sagittal, axial, and axial oblique planes, and T1W axial
sequences of the pelvis and lower abdomen. All axial oblique
images are obtained in a plane perpendicular to the endome-
trial cavity (12). Dynamic contrast enhanced MRI after
administration of 0.1 mmol of gadolinium per kilogram body
weight (pump injection) was performed by using the multi-
phase technique (sagittal and axial oblique before contrast
and at 25 s, 1 min, and 2 min in the sagittal plane and at
4 min in the axial oblique plane after contrast). Axial images
of the lower abdomen were also done to detect lymphadenop-
athy using axial fast imaging employing steady-state acquisi-
tion. Imaging parameters were as follows: repetition time/
echo time, 3.6:1.75 ms; number of excitations, 0.75; matrix,
288_192; ﬁeld of view, 36 cm; section thickness, 4 mm interpo-
lated to 2 mm.
2.1. Image interpretation
MR images were analyzed without knowing the ﬁnal histopa-
thology results at the time of examination. The MR images
were evaluated independently by two radiologists (A.M and
Y.M); disagreement was resolved by joint reevaluation.
The unenhanced images (T1 and T2 WIs) were evaluated
initially and staging was assigned for each case. An identical
scoring system was used to evaluate the DCE-MRI according
to the revised FIGO staging system.
In T2 WIs, no myometrial inﬁltration was considered when
the junctional zone (JZ) was intact and the tumor is conﬁned
to the endometrium. Superﬁcial myometrial inﬁltration was
considered when focal disruption of the JZ was present while
complete disruption of the JZ indicated deep myometrial inﬁl-
tration. The junctional zone on T2 WIs appears as a band of
low signal intensity immediately subjacent to the endometrial
stripe.s
lf myometrial invasion
or more than half of the myometrial invasion
vical stroma, but does not extend beyond the uterus
nal spread of the tumor
, adnexa, or positive peritoneal cytology
and/or parametrial involvement
c and/or para-aortic lymph nodes
es
c nodes with or without positive pelvic nodes
dder and/ or bowel mucosa, and/or distant metastases
bladder and/or bowel mucosa
, including intra-abdominal metastases and/or inguinal lymph nodes
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metrium secondary to uterine involution, which could make
accurate assessment of the depth of myometrial invasion chal-
lenging at conventional MR imaging (12).
Intact subendometrial enhancement (SEE) band on DCE-
MRI indicates no myometrial invasion. In cases where the SEE
band was not visible, a smooth tumor-to-myometrium interface
indicated a tumor conﬁned to the endometrium. Superﬁcial myo-
metrial invasion was diagnosed when the SEEwas interrupted or
the interface between the tumor and the myometriumwas irregu-
lar, with low signal intensity tumor involving less than 50% of
myometrial thickness. Extension of the tumor beyond 50% of
myometrium thickness indicated deep myometrial invasion.
Regarding cervical inﬁltration, abnormal signal intensity on
T2 WIs extending into the cervical canal or stroma or widening
of the cervical canal was considered cervical involvement. On
DCE-MRI, disruption of cervical epithelium enhancement
was considered cervical involvement.
In T2 WIs, lymph nodes show intermediate signal intensity
compared to the adjacent hypointense blood vessels. Necrosis
appears as an area of low signal intensity. In the post contrast
images, normal lymph nodes show homogenous enhancement
and areas of necrosis appear as non enhancing areas.
2.2. Surgical analysis
Total hysterectomy with bilateral salpingo-oophorectomy and
lymph node dissection is the standard staging procedure for
endometrial carcinoma. Vaginal, laparoscopic or robot-as-
sisted approaches are also possible nowadays (13).
As with other abdominal gynecologic malignancies; com-
plete staging of endometrial carcinoma includes biopsy of
any area where metastases are suspected. Pelvic and para-aor-
tic lymph node sampling is done selectively (14).
Vaginal hysterectomy is not recommended for endometrial
carcinoma staging since it precludes examination of the abdo-
men and lymph nodes for metastases. However, it is performed
for women who are poor candidates for surgery (15,16).
Lymph node dissection was done with anatomic labeling
into each group. The total number of metastatic lymph nodes
was documented by the pathologist.
2.3. Statistical analysis
The sensitivity, speciﬁcity, PPV, NPV, and overall diagnostic
accuracy for the T2W images alone and combined T2WI and
DCE-MRI were calculated. The hypothesis of no dispropor-
tionate change between assessments (i.e., correct, incorrect
assessments) made using the T2WI alone and combined
T2WI and DCE-MRI method was tested using the McNemar
test. Associations between assessment of depth of myometrial
invasion and possible pitfalls previously mentioned on T2W
images were examined by implementing Fisher exact test. PG
0.05 was considered statistically signiﬁcant. All analyses were
performed using SPSS Version 14 and Stat-Exact 4.3. Results
Endometrial cancer is isointense relative to the hypointense
normal endometrium on unenhanced T1 WIs. On T2 WIs; itmost commonly shows heterogeneous intermediate signal
intensity relative to the hyperintense normal endometrium
and mildly hyperintense relative to the normal myometrium
(17).
Endometrial tumors enhance earlier than does the normal
endometrium after administration of intravenous contrast
medium (CM), which aids in the detection of small tumors
conﬁned to the endometrial complex. Normal myometrium en-
hances intensely compared with hypointense endometrial tu-
mor. Maximum contrast between hyperintense myometrium
and hypointense endometrial tumor occurs 50–120 s after
CM administration, and this is the most important phase for
accurate assessment of the depth of myometrial invasion (18)
(Fig. 1). Delayed-phase images obtained 3–4 min after CM
administration are useful in the evaluation of cervical stromal
invasion (Fig. 2). The presence of an intact enhancing cervical
mucosa excludes stromal invasion. The cervical epithelium
normally shows a signiﬁcant enhancement more than the tu-
mor (8).
In our study, total hysterectomy and bilateral salpingo-
oophorectomy were done in all cases. 15 patients (37.5%)
underwent open total abdominal hysterectomy (TAH) and
25 patients (62.5%) underwent laparoscopic approach. Eight
out of 40 patients (20%) underwent lymph node sampling
while 13 cases (32.5%) underwent pelvic and aortic lymphad-
enectomy. This decision was based on the presence of an ex-
tra-uterine disease and possible lymph node involvement on
MR studies.
The surgical specimens were examined pathologically by
specialized pathologists to detect the depth of myometrial
invasion, the presence of cervical stroma invasion and the pres-
ence of metastasis within the sampled lymph nodes.
3.1. Myometrial inﬁltration
Regarding the depth of myometrial inﬁltration, agreement be-
tween T2 WIs and pathology was found in 31/40 patients
(77.5%) while agreement between DCE-MRI and pathology
was found in 38/40 patients (95%). The sensitivity, speciﬁcity,
PPV, NPV and diagnostic accuracy of T2 WIs in the detection
of deep myometrial invasion were 80%, 72%, 70%, 84% and
79%, respectively and 87%, 90%, 85%, 92% and 87%, respec-
tively for the DCE-MR images (Figs. 3 and 4). Of note, the
addition of DCE-MRI led to a correct detection of deep myo-
metrial invasion in all cases.
The diagnostic performance of T2 WIs and DCE-MRI in
the assessment of depth of myometrial invasion is shown in
Table 2.
3.2. Cervical inﬁltration
T2 WIs showed sensitivity of 78.5%, speciﬁcity of 88%, PPV
of 73%, NPV of 90.5% and diagnostic accuracy of 82.5%
while DCE-MRI showed 92% sensitivity, 97% speciﬁcity,
92% PPV, 97% NPV and 95% diagnostic accuracy (Table 3).
11 out of 40 patients (27.5%) had pathologically proven
cervical stromal invasion. T2 WIs could correctly diagnose 8
out of these 11 cases with 3 false-negative diagnoses. Of the
29 patients (72.5%) without histologic diagnosis of cervical
involvement, a false-positive diagnosis was made with T2
WIs in 4 patients. DCE-MRI could correctly diagnose 10
Fig. 1 Sagittal T2W FRFSE (A) shows an endometrial carcinoma in a 90-year-old woman presenting with vaginal bleeding. There is a
poor tumor-to-myometrium contrast especially anteriorly (arrow) leading to an overestimation of depth of myometrial invasion on T2WI
only (deep invasion) especially in the presence of thin myometrium secondary to uterine involution. Sagittal gadolinium-enhanced fat-
suppressed T1WIs FSPGR (B) demonstrate superﬁcial myometrial invasion by the tumor (arrow) which was conﬁrmed histologically.
Fig. 2 Sagittal T2W FRFSE (A) shows an endometrial carcinoma in a 36-year-old woman presenting with vaginal bleeding. The tumor
ﬁlls the endometrial cavity with superﬁcial invasion of the myometrium and extends into the cervical canal (arrows). Sagittal gadolinium-
enhanced fat-suppressed T1WI FSPGR (B) conﬁrms the superﬁcial myometrial invasion and cervical extension which were conﬁrmed
surgically.
Fig. 3 Sagittal T2W FRFSE (A) shows polypoidal endometrial carcinoma in a 61-year-old woman with poor tumor-to-myometrium
contrast especially posteriorly (arrows) leading to an overestimation of depth of myometrial invasion on T2WI alone (thought to be
superﬁcial myometrial invasion) and no clear cervical extension. The sagittal gadolinium-enhanced T1W fat-suppressed MR image (B)
demonstrates a well deﬁned tumor-to-myometrium interface (arrow) indicating no myometrial invasion with extension of the tumor into
the endocervix (arrowhead) which were conﬁrmed at the ﬁnal histologic ﬁnding.
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Fig. 4 Sagittal T2W FRFSE (A) shows an endometrial carcinoma in a 78-year-old woman presenting with vaginal bleeding and deep
myometrial inﬁltration anteriorly. The dynamic contrast enhanced image (B) demonstrates superﬁcial myometrial invasion superiorly and
anteriorly (arrows) which was conﬁrmed at the ﬁnal histologic ﬁnding.
Table 2 Number and percentage of patients correctly identi-
ﬁed radiologically with myometrial invasion compared with
surgicopathological ﬁndings.
MR Finding T2W DCE
No myometrial invasion 57 (4/7) 85.7 (6/7)
<50% myometrial invasion 82.6 (19/23) 95.6 (22/23)
>50% myometrial invasion 80.0 (8/10) 100.0 (10/10)
Table 3 Percentage of Cervical Involvement by the MRI
techniques.
MRI Technique Sensitivity Speciﬁcity PPV NPV Accuracy
T2 WIs 78.5 88 73 90.5 82.5
DCE-MRI 92 97 92 97 95
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tumor extension beyond the internal os microscopically. One
out of 29 patients without cervical inﬁltration was misdiag-
nosed as a false positive case which could be due to the pres-
ence of large cervical polyp which was misdiagnosed as
tumor extension.
3.3. Lymph node
The MRI showed 100% sensitivity and 85% speciﬁcity for
both T2WIs and DCE-MRI in detecting lymph node metasta-
sis. MR imaging assessment of lymph node status resulted in
one (4.7%) of 21 patients with true-positive, 18 (85.7%) of
21 patients with true-negative, one (4.7%) of 21 patients with
false-positive, and one (4.7%) of 21 patients with false-nega-
tive ﬁndings.
4. Discussion
The histological grade and the stage of endometrial carcinoma
can predict the occurrence of extra uterine spread and lymph
node metastases (19,4,20). It can also affect the prognosisand treatment as patients with early stage disease need in most
of the cases minimally invasive surgery such as simple hyster-
ectomy while patients at high risk of extra uterine disease or
nodal metastases (grade 3, deep myometrial and/or cervical
inﬁltration), will beneﬁt from lymphadenectomy and preoper-
ative or postoperative radiation therapy (3,21–23).
Staging of endometrial tumors is usually done surgically,
but MRI is now widely used as a non-invasive imaging modal-
ity in predicting myometrial and cervical invasion and to detect
lymph node involvement (24).
Although MRI is now widely used for preoperative staging
of endometrial carcinoma, there is still no certain imaging pro-
tocol which is universally accepted (10,25,11).
In our study, we try to detect the usefulness of DCE-MRI
in the accurate evaluation of depth of myometrial inﬁltration
and cervical stromal involvement in cases of endometrial
carcinoma.
Our results showed that the addition of DCE-MRI to the
T2WIs resulted in a signiﬁcant improvement in the accuracy
of assessment of deep myometrial invasion and cervical stro-
mal invasion and lymph node enlargement.
In addition, DCE-MRI led to a correct identiﬁcation of
deep myometrial invasion in all cases. These results were very
close to those found by Sala et al., (2) but were different from
those done by Rockall et al., (25) in which the dynamic
enhancement did not improve the diagnostic performance in
84 patients. However, this study was done over a 10-year per-
iod, and during this time MRI technology and protocols im-
proved signiﬁcantly. Our results were very close to those
found by Sala et al., (2) probably because it was recently done,
so they used nearly the same protocol and the same machine as
we used. Their study showed 91.4% sensitivity, 80% speciﬁc-
ity, 91.4% PPV and 80% NPV of T2WIs in accurate detection
of depth of myometrial invasion increasing to 97.1% sensitiv-
ity, 100% speciﬁcity, 100% PPV and 93.7% NPV for com-
bined T2 and DCE T1 WIs.
Zandrino et al., (5) results also proved the usefulness of
DCE-MRI in cases of endometrial tumors in which T2 WIs
showed sensitivity of 85%, speciﬁcity of 76%, PPV of 73%
and NVP of 87% in accurate detection of depth of myometrial
invasion while post contrast T1WIs showed sensitivity of 90%,
speciﬁcity of 80%, PPV of 82% and NPV of 89%.
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found by Chung et al., (9) in which administration of gadolin-
ium did not distinguish myometrial invasion of tumor from
normal myometrium in a subset of 24 patient study. But again,
their study was done over a 9 year period where changes in the
technique and practice may have had an effect and the study
was done in a small number of patients.
Some other authors did not ﬁnd signiﬁcant differences be-
tween non-contrast and contrast-enhanced MRI especially
when high-resolution T2 WIs was used (26,27).
On the other hand, many researches other than those done
by Sala et al., (2) supported the routine use of dynamic IV con-
trast enhancement to improve the accuracy of assessment of
depth of myometrial invasion (accuracy of 55–77% for
T2WIs vs 85–91% for DCE-MRI) (11,25,28). In a recent pro-
spective study, Manfredi et al., (10) showed the importance of
dynamic MRI as it allows detection of different enhancement
times of the endometrial tumor compared with the adjacent
normal myometrium.
Many other papers reported a better diagnostic perfor-
mance of DCE-MRI (accuracy 85–95% vs 58–78%)
(24,29,30).
The addition of DCE-MRI could clearly differentiate the
intensely enhancing normal myometrium from the relatively
poorly enhancing tumor.
In our study, the JZ was found to be a useful landmark for
determining the presence or absence of myometrial invasion.
The JZ was present in most of our patients [35 out of 40] unlike
other authors in which the JZ was not present in most of their
cases (17,18). Chung et al., (9) also found that the JZ was pre-
served in most of their patients regardless of the menopausal
status, but they did not ﬁnd it useful in assessing deep myome-
trial invasion.
On T2 WIs, the relationship between the tumor and the JZ
is highly predictive of deep myometrial inﬁltration (5). Unfor-
tunately, in post menopausal patients, patients with large
endometrial tumors, multiple or large leiomyomas, small or
retroverted uterus, uterus with congenital anomalies or cases
of adenomyosis, the zonal anatomy may be difﬁcult to identify
and overstaging or understaging may occur (20,23,24,31,32).
In the 9 cases of staging error on T2 WIs in our study, 3 pa-
tients were post menopausal but the rest of the cases had nor-
mal uterine morphology and no abnormalities found at
pathological examination.
DCE-MRI is more helpful than T2WIs in cases of thick-
ened or ill deﬁned junctional zone as it allows a clear differen-
tiation between the tumor, endometrium and myometrium. It
is also more helpful in cases of large tumors causing thinning
of the myometrium.
MRI was also found to be very accurate in the detection of
cervical stromal invasion. This is similar to the results found by
Manfredi et al., (10), Seki et al., (33) and Nagar et al., (34)
which showed the accuracy of MRI in detecting cervical stro-
mal invasion reaching 92% with sensitivities of 75–84% and
speciﬁcities of 94–96%.
Some authors reported that T2WIs seem to have a better
diagnostic performance than contrast-enhanced sequences.
T2WIs can discriminate hyperintense tumor disrupting low-
signal-intensity cervical stroma while, after contrast, tumor
and stroma may have a similar enhancement. However; con-
trast agent may be useful to differentiate tumor from endocer-
vical debris and to detect the lesion in cases of superﬁcialinﬁltration, when hyperintense tumor and epithelium cannot
be discriminated on T2WIs (23).
False positive results in DCE-MRI could occur in cases of
chronic cervicitis.
Our study showed higher speciﬁcity and positive predictive
value for assessing cervical involvement with DCE-MRI than
T2 WIs as the former can detect the continuity of enhancing
cervical epithelium which excludes cervical inﬁltration as
false-positive cases of cervical inﬁltration in T2WIs caused
by a dilated cervical canal without cervical involvement. In
most cases, enhancement of the cervical epithelium was greater
than that of the tumor and cervical stroma especially, in phase
2 or 3 of the dynamic MR imaging.
In our study, only patients with MR evidence of lymph
node enlargement underwent lymphadenectomy which led to
an overestimation of the accuracy of MRI in predicting lymph
node metastases.
The limitation of MRI in the assessment of lymph node
metastasis is that it depends on the size of the lymph nodes
using 1 cm as a cutoff value or the presence of areas of central
necrosis. Some metastatic lymph nodes are less than 1 cm lead-
ing to false negative results while others proved to be non met-
astatic although they were larger than 1 cm leading to false
positive results. Some metastatic lymph nodes do not show
necrosis whatever the size of the node.5. Conclusion
DCE-MRI can signiﬁcantly increase the accuracy of MRI in
the assessment of depth of myometrial inﬁltration and cervical
invasion in cases of endometrial carcinoma and may be a use-
ful tool to guide the surgical approach in these cases and select
patients which will beneﬁt from neoadjuvant chemotherapy or
radiation therapy. DCE-MRI adds only about 4 min to the to-
tal time of the study.
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